Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
-Advocacy and Legislative Updates
 Medical News
 Blood Safety News
 NHF and Community News
 Industry News
 Travel Advisory

 

 

 
Health Reform in Your Backyard: State Exchange Update
 

The State Exchange Project held the second in a series of four informational webinars. “Health Reform in Your Backyard— State Exchange Update: What State Advocates Need to Know,” on Tuesday, May 15, 2012, with more than 60 advocates participating. It provided an overview of health insurance exchanges (the state-based marketplaces that will offer new coverage options starting in 2014), how exchanges are expected to fit in with other market reforms and coverage expansions under the Affordable Care Act, and information on where states must meet federal requirements and where they have flexibility in designing and implementing their exchange. The webinar also highlighted current state efforts and discussed ways advocates can get involved in their state. JoAnn Volk, research professor at Georgetown’s Health Policy Institute, served as the presenter. Recorded copies of this webinar and accompanying handouts are available for download on NHF’s Web site: www.hemophilia.org.

The American Plasma Users Coalition (A-PLUS) is a coalition of national patient advocacy organizations, including the National Hemophilia Foundation, created to represent the unique needs of more than 170,000 patients with rare diseases who use life-saving plasma protein therapies.   The coalition launche the State Exchange Project to educate state-based community advocates about the health reform implementation process and equip them to help shape it. The program is targeted to chapter staff and other key community advocates. 

Special thanks to our lead sponsors, CSL Behring and Pfizer, and to supporting sponsors Baxter, Bayer, Novo Nordisk, Grifols and Accredo.
 

This section of our Web site is sponsored by: